Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophilsJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62023-04-183OAAI
Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanomaJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-09-2912OAAI
INTRATUMOR CHILDHOOD VACCINE-SPECIFIC CD4+T CELL RECALL HELPS ANTITUMOR CD8 T CELLSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-101OA
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanomaJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-04-1950OAAI
A PHASE I TRIAL OF INTRATUMORAL PVSRIPO IN PATIENTS WITH UNRESECTABLE TREATMENT REFRACTORY MELANOMAJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-11-090PREAI